Craig-Hallum Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $24

Benzinga Newsdesk www.benzinga.com Neutral 56.4%

Neg 0% Neu 56.4% Pos 0%

Craig-Hallum analyst Adam Vogel initiates coverage on Satellos Bioscience (NASDAQ:MSLE) with a Buy rating and announces Price Target of $24.